Scientist.com Partners with Top Pharma to Launch COMPLI™, a Global Compliance Standard for Human Biosample Acquisition
Scientist.com, the world's leading marketplace for outsourced scientific services, today announced the launch of a global process for the ethical sourcing of human biosamples using its COMPLI™ functionality. Created in partnership with leading pharmaceutical companies, suppliers and biobank organizations such as the ESBB and UKCRC TCC, COMPLI™ introduces a common, comprehensive process and supply agreement supporting access to human biosamples. The goal is to enable biobanks and other well-known human sample suppliers to more easily connect with researchers in the pharmaceutical and biotech industries and academia.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170921005353/en/
“By simplifying and standardizing processes that previously took months, this initiative should shorten the research cycle and increase the pace of research,” stated Dr. Matharoo-Ball, President Elect, European, Middle Eastern and African Society for Biopreservation and BioBanking (ESBB). “We are pleased to support the development of a standard process that allows us all to rapidly utilise correctly consented human biosamples in an ethically compliant manner.”
Human biological samples, such as organs, tissues and genetic material, are increasingly being used in drug research, but until now there has been no common process governing their acquisition. The new COMPLI™ process helps researchers and suppliers adhere to internal and external (often legislative) procurement policies. It also ensures that appropriate donor consents have been obtained, tracked and communicated throughout the supply chain.
“It is still possible today to purchase human biological samples without any oversight whatsoever, putting all parties at considerable risk if samples are used inappropriately,” stated Matt McLoughlin, Senior Director of Compliance at Scientist.com. “The launch of COMPLI™ will significantly reduce the risks associated with using human samples. It will also enable researchers to gain faster access to critical research tools needed to respond to global health emergencies.”
COMPLI™ establishes a rigorous compliance and governance framework that increases visibility, traceability and control for the scientific research community. It is only available through the Scientist.com marketplace.
Scientist.com is the world's leading scientific services marketplace. The marketplace simplifies research sourcing, saves time and money and provides access to innovative tools and technologies - while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies and the US National Institutes of Health (NIH). Visit scientist.com to learn more.
Director of Communications
858-455-1300 ext. 401
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CELLTRION15.12.2017 23:15 | pressemeddelelse
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar
TAKEDA15.12.2017 13:36 | pressemeddelelse
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
TWISPAY15.12.2017 13:23 | pressemeddelelse
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards
PEACE-FORUM15.12.2017 12:40 | pressemeddelelse
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum
CA-KENNEDY-WILSON15.12.2017 12:02 | pressemeddelelse
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million
NV-NAC-FOUNDATION15.12.2017 10:02 | pressemeddelelse
AML BitCoin Enters Phase II of ICO
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum